Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 6.13729135 |
2 | viral transcription (GO:0019083) | 5.92972014 |
3 | translational termination (GO:0006415) | 5.75600728 |
4 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.34402317 |
5 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.18540808 |
6 | maturation of SSU-rRNA (GO:0030490) | 5.14860499 |
7 | telomere maintenance via semi-conservative replication (GO:0032201) | 5.14646823 |
8 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.11419546 |
9 | ribosomal small subunit biogenesis (GO:0042274) | 5.10739737 |
10 | translational elongation (GO:0006414) | 5.10086288 |
11 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.09865517 |
12 | DNA strand elongation (GO:0022616) | 5.09693932 |
13 | cotranslational protein targeting to membrane (GO:0006613) | 4.98292163 |
14 | protein targeting to ER (GO:0045047) | 4.96735776 |
15 | DNA deamination (GO:0045006) | 4.93314009 |
16 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.75505839 |
17 | DNA unwinding involved in DNA replication (GO:0006268) | 4.73481863 |
18 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.70281024 |
19 | protein localization to endoplasmic reticulum (GO:0070972) | 4.67063401 |
20 | translational initiation (GO:0006413) | 4.54152267 |
21 | viral life cycle (GO:0019058) | 4.52109332 |
22 | cellular protein complex disassembly (GO:0043624) | 4.43756273 |
23 | telomere maintenance via recombination (GO:0000722) | 4.43458971 |
24 | DNA replication initiation (GO:0006270) | 4.42261982 |
25 | ribosomal large subunit biogenesis (GO:0042273) | 4.31775610 |
26 | mannose metabolic process (GO:0006013) | 4.29176554 |
27 | protein complex disassembly (GO:0043241) | 4.11561385 |
28 | mitotic recombination (GO:0006312) | 4.09179531 |
29 | GDP-mannose metabolic process (GO:0019673) | 3.97583628 |
30 | macromolecular complex disassembly (GO:0032984) | 3.91767305 |
31 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.88119624 |
32 | DNA replication checkpoint (GO:0000076) | 3.84070554 |
33 | telomere maintenance via telomere lengthening (GO:0010833) | 3.83380817 |
34 | nucleobase biosynthetic process (GO:0046112) | 3.82952232 |
35 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.78453094 |
36 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.75503863 |
37 | formation of translation preinitiation complex (GO:0001731) | 3.65496086 |
38 | mRNA catabolic process (GO:0006402) | 3.64577616 |
39 | RNA catabolic process (GO:0006401) | 3.54054541 |
40 | protein localization to kinetochore (GO:0034501) | 3.52660892 |
41 | translation (GO:0006412) | 3.51824884 |
42 | response to peptidoglycan (GO:0032494) | 3.51677847 |
43 | negative regulation of RNA splicing (GO:0033119) | 3.50010425 |
44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45520907 |
45 | rRNA processing (GO:0006364) | 3.45041114 |
46 | IMP biosynthetic process (GO:0006188) | 3.43061271 |
47 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.42754481 |
48 | regulation of translational fidelity (GO:0006450) | 3.41887811 |
49 | proline biosynthetic process (GO:0006561) | 3.40312151 |
50 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40195971 |
51 | pseudouridine synthesis (GO:0001522) | 3.32706287 |
52 | rRNA metabolic process (GO:0016072) | 3.31625834 |
53 | translesion synthesis (GO:0019985) | 3.28445124 |
54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25217548 |
55 | CENP-A containing nucleosome assembly (GO:0034080) | 3.24968698 |
56 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.24455456 |
57 | UV protection (GO:0009650) | 3.24170706 |
58 | protein targeting to membrane (GO:0006612) | 3.22327421 |
59 | spliceosomal snRNP assembly (GO:0000387) | 3.21067510 |
60 | protein localization to chromosome, centromeric region (GO:0071459) | 3.19649616 |
61 | IMP metabolic process (GO:0046040) | 3.19199824 |
62 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.19197567 |
63 | DNA replication-independent nucleosome organization (GO:0034724) | 3.19197567 |
64 | tRNA methylation (GO:0030488) | 3.17987408 |
65 | folic acid metabolic process (GO:0046655) | 3.16669121 |
66 | histone H2A acetylation (GO:0043968) | 3.16654984 |
67 | ncRNA 3-end processing (GO:0043628) | 3.16122730 |
68 | intra-S DNA damage checkpoint (GO:0031573) | 3.15215017 |
69 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.15118436 |
70 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.14313207 |
71 | chromatin remodeling at centromere (GO:0031055) | 3.12387274 |
72 | purine nucleobase biosynthetic process (GO:0009113) | 3.09361814 |
73 | ribosome biogenesis (GO:0042254) | 3.09051912 |
74 | proteasome assembly (GO:0043248) | 3.06316841 |
75 | DNA duplex unwinding (GO:0032508) | 3.06215886 |
76 | spliceosomal complex assembly (GO:0000245) | 3.05460998 |
77 | DNA geometric change (GO:0032392) | 3.03896770 |
78 | regulation of monocyte differentiation (GO:0045655) | 3.03813398 |
79 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 3.03173049 |
80 | mRNA splicing, via spliceosome (GO:0000398) | 3.03173049 |
81 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.00562912 |
82 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.00562912 |
83 | RNA splicing, via transesterification reactions (GO:0000375) | 3.00510901 |
84 | response to muramyl dipeptide (GO:0032495) | 3.00216443 |
85 | mitochondrial DNA replication (GO:0006264) | 2.98771405 |
86 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.98745888 |
87 | establishment of integrated proviral latency (GO:0075713) | 2.98679136 |
88 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.97684821 |
89 | termination of RNA polymerase II transcription (GO:0006369) | 2.97285331 |
90 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.96309719 |
91 | viral mRNA export from host cell nucleus (GO:0046784) | 2.95426209 |
92 | regulation of chromatin binding (GO:0035561) | 2.93453347 |
93 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.93175119 |
94 | histone mRNA metabolic process (GO:0008334) | 2.90962112 |
95 | NIK/NF-kappaB signaling (GO:0038061) | 2.90921899 |
96 | telomere organization (GO:0032200) | 2.90525743 |
97 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.89904614 |
98 | telomere maintenance (GO:0000723) | 2.89788653 |
99 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.88362676 |
100 | negative regulation of mRNA processing (GO:0050686) | 2.87039841 |
101 | cellular component biogenesis (GO:0044085) | 2.86090970 |
102 | base-excision repair (GO:0006284) | 2.83748324 |
103 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.82371321 |
104 | modulation by virus of host process (GO:0019054) | 2.80502005 |
105 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.80430772 |
106 | mature B cell differentiation involved in immune response (GO:0002313) | 2.80390487 |
107 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.80231754 |
108 | ncRNA processing (GO:0034470) | 2.78972884 |
109 | Peyers patch development (GO:0048541) | 2.78637431 |
110 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.78637431 |
111 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.77913709 |
112 | termination of RNA polymerase III transcription (GO:0006386) | 2.77913709 |
113 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.77244808 |
114 | pentose-phosphate shunt (GO:0006098) | 2.73253730 |
115 | negative regulation of cell size (GO:0045792) | 2.73163847 |
116 | protein retention in ER lumen (GO:0006621) | 2.71701861 |
117 | positive thymic T cell selection (GO:0045059) | 2.71090434 |
118 | snRNA metabolic process (GO:0016073) | 2.70831658 |
119 | Golgi transport vesicle coating (GO:0048200) | 2.70672914 |
120 | COPI coating of Golgi vesicle (GO:0048205) | 2.70672914 |
121 | mismatch repair (GO:0006298) | 2.69797366 |
122 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.69365691 |
123 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.68298309 |
124 | negative regulation of granulocyte differentiation (GO:0030853) | 2.67554542 |
125 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.66429771 |
126 | tRNA modification (GO:0006400) | 2.65724082 |
127 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.65643083 |
128 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.65404536 |
129 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.65404536 |
130 | ncRNA metabolic process (GO:0034660) | 2.64818932 |
131 | metallo-sulfur cluster assembly (GO:0031163) | 2.64139560 |
132 | iron-sulfur cluster assembly (GO:0016226) | 2.64139560 |
133 | DNA-dependent DNA replication (GO:0006261) | 2.64041534 |
134 | snRNA processing (GO:0016180) | 2.63340230 |
135 | kinetochore organization (GO:0051383) | 2.62142341 |
136 | regulation of protein heterodimerization activity (GO:0043497) | 2.61634338 |
137 | apoptotic process involved in morphogenesis (GO:0060561) | 2.61116161 |
138 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.60197552 |
139 | pentose metabolic process (GO:0019321) | 2.60187209 |
140 | protein-DNA complex disassembly (GO:0032986) | 2.56748760 |
141 | nucleosome disassembly (GO:0006337) | 2.56748760 |
142 | modulation by symbiont of host cellular process (GO:0044068) | 2.54264025 |
143 | positive regulation of B cell differentiation (GO:0045579) | 2.51772839 |
144 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.51023092 |
145 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.51022302 |
146 | thymic T cell selection (GO:0045061) | 2.49998234 |
147 | actin nucleation (GO:0045010) | 2.49255693 |
148 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.48898344 |
149 | negative regulation of B cell apoptotic process (GO:0002903) | 2.47727856 |
150 | pinocytosis (GO:0006907) | 2.47397224 |
151 | glycosphingolipid catabolic process (GO:0046479) | 2.47292384 |
152 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.46114951 |
153 | N-acetylneuraminate metabolic process (GO:0006054) | 2.44198403 |
154 | histone arginine methylation (GO:0034969) | 2.41060422 |
155 | peptidyl-arginine N-methylation (GO:0035246) | 2.40576019 |
156 | peptidyl-arginine methylation (GO:0018216) | 2.40576019 |
157 | positive regulation by symbiont of host defense response (GO:0052509) | 2.40332046 |
158 | modulation by symbiont of host defense response (GO:0052031) | 2.40332046 |
159 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.40332046 |
160 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.40332046 |
161 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.40332046 |
162 | modulation by symbiont of host immune response (GO:0052553) | 2.40332046 |
163 | regulation of gamma-delta T cell activation (GO:0046643) | 2.39395816 |
164 | dosage compensation (GO:0007549) | 2.39140967 |
165 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.38558701 |
166 | regulation of mast cell degranulation (GO:0043304) | 2.38389023 |
167 | histone H4 deacetylation (GO:0070933) | 2.36949193 |
168 | regulation of histone H3-K27 methylation (GO:0061085) | 2.35973426 |
169 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.34592298 |
170 | regulation of superoxide anion generation (GO:0032928) | 2.34348223 |
171 | amino sugar catabolic process (GO:0046348) | 2.34317044 |
172 | nucleotide salvage (GO:0043173) | 2.32526767 |
173 | glucose catabolic process (GO:0006007) | 2.29214903 |
174 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.28281854 |
175 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.28052160 |
176 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.27651324 |
177 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.26643497 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.77739084 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.04830101 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.93388737 |
4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.06263752 |
5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.91748874 |
6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.85844403 |
7 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.82544050 |
8 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.79796766 |
9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.78789354 |
10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.78506159 |
11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.76785634 |
12 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.75272630 |
13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.68506582 |
14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.67993574 |
15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.67654396 |
16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.60875477 |
17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.52420608 |
18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.46388234 |
19 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.45581429 |
20 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.43752923 |
21 | MYC_22102868_ChIP-Seq_BL_Human | 2.38162040 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.35718475 |
23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29659678 |
24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.27688729 |
25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.23290778 |
26 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18535382 |
27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.14890048 |
28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.06994776 |
29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.05191296 |
30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.99646913 |
31 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.97794533 |
32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.96279178 |
33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94900158 |
34 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93782552 |
35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.91962723 |
36 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.88228685 |
37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.87993192 |
38 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.87218570 |
39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87192961 |
40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.86047664 |
41 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.85630466 |
42 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.81762167 |
43 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79868076 |
44 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.78864989 |
45 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77490499 |
46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.76731495 |
47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76498966 |
48 | P68_20966046_ChIP-Seq_HELA_Human | 1.75809649 |
49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73129393 |
50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.69536409 |
51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68490746 |
52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.66673053 |
53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65164634 |
54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.64307377 |
55 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.64209480 |
56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.59226917 |
57 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.57861290 |
58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.57231507 |
59 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.54721523 |
60 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53605864 |
61 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.53239600 |
62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.53016389 |
63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52820513 |
64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51319328 |
65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50603346 |
66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.49429183 |
67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.49288324 |
68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48950333 |
69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48225652 |
70 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.47764001 |
71 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47402175 |
72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47357700 |
73 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.47193006 |
74 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46352533 |
75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46062078 |
76 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44786174 |
77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42414430 |
78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41850344 |
79 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.41636199 |
80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40944806 |
81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39697109 |
82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38314243 |
83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38158185 |
84 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36516779 |
85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33688625 |
86 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.32373810 |
87 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.31175585 |
88 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30827687 |
89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30072109 |
90 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.30008374 |
91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26818946 |
92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26431248 |
93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25036508 |
94 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24921408 |
95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22337137 |
96 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21583995 |
97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21195195 |
98 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21165273 |
99 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18567977 |
100 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.18284485 |
101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.18204154 |
102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17967390 |
103 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.17426307 |
104 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.15088155 |
105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14930847 |
106 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.14689995 |
107 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14577910 |
108 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14292607 |
109 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.14231196 |
110 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13347090 |
111 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13304125 |
112 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13041157 |
113 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12692728 |
114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09791844 |
115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09568437 |
116 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.08914674 |
117 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08452153 |
118 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.08361430 |
119 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08200747 |
120 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.07799566 |
121 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07747596 |
122 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07424499 |
123 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.06912476 |
124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06887780 |
125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06773925 |
126 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.06161907 |
127 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06073767 |
128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.05616964 |
129 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05265865 |
130 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04750700 |
131 | MAF_26560356_Chip-Seq_TH1_Human | 1.04705433 |
132 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04299123 |
133 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04189080 |
134 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03825048 |
135 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03375446 |
136 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.99154380 |
137 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98659413 |
138 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.98319481 |
139 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98144108 |
140 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95464546 |
141 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.95436355 |
142 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94222872 |
143 | MAF_26560356_Chip-Seq_TH2_Human | 0.92332464 |
144 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91789966 |
145 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91589156 |
146 | MYB_26560356_Chip-Seq_TH2_Human | 0.89849848 |
147 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.87081967 |
148 | MYB_26560356_Chip-Seq_TH1_Human | 0.86863550 |
149 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.85152001 |
150 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.84083758 |
151 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83696814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 4.57561502 |
2 | MP0010094_abnormal_chromosome_stability | 4.02687460 |
3 | MP0004957_abnormal_blastocyst_morpholog | 3.66126928 |
4 | MP0002396_abnormal_hematopoietic_system | 3.64763873 |
5 | MP0005451_abnormal_body_composition | 3.45339734 |
6 | MP0003111_abnormal_nucleus_morphology | 3.45226711 |
7 | MP0003077_abnormal_cell_cycle | 3.28411176 |
8 | MP0008057_abnormal_DNA_replication | 2.97947045 |
9 | MP0008058_abnormal_DNA_repair | 2.78594082 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.76429669 |
11 | MP0008007_abnormal_cellular_replicative | 2.60447265 |
12 | MP0005174_abnormal_tail_pigmentation | 2.56623098 |
13 | MP0003303_peritoneal_inflammation | 2.56139447 |
14 | MP0000678_abnormal_parathyroid_gland | 2.52289289 |
15 | MP0000490_abnormal_crypts_of | 2.30913431 |
16 | MP0004808_abnormal_hematopoietic_stem | 2.24990450 |
17 | MP0008932_abnormal_embryonic_tissue | 2.20444033 |
18 | MP0003763_abnormal_thymus_physiology | 2.14703764 |
19 | MP0008260_abnormal_autophagy | 2.13773615 |
20 | MP0005075_abnormal_melanosome_morpholog | 2.07225712 |
21 | MP0002398_abnormal_bone_marrow | 2.03672234 |
22 | MP0001835_abnormal_antigen_presentation | 1.97223603 |
23 | MP0009333_abnormal_splenocyte_physiolog | 1.93511785 |
24 | MP0003705_abnormal_hypodermis_morpholog | 1.90008688 |
25 | MP0006054_spinal_hemorrhage | 1.86784362 |
26 | MP0000685_abnormal_immune_system | 1.86644750 |
27 | MP0000703_abnormal_thymus_morphology | 1.81052605 |
28 | MP0002722_abnormal_immune_system | 1.78251709 |
29 | MP0004185_abnormal_adipocyte_glucose | 1.77186963 |
30 | MP0000689_abnormal_spleen_morphology | 1.73406794 |
31 | MP0000350_abnormal_cell_proliferation | 1.70399204 |
32 | MP0001800_abnormal_humoral_immune | 1.66089103 |
33 | MP0001730_embryonic_growth_arrest | 1.64136994 |
34 | MP0000465_gastrointestinal_hemorrhage | 1.63455890 |
35 | MP0005397_hematopoietic_system_phenotyp | 1.60077720 |
36 | MP0001545_abnormal_hematopoietic_system | 1.60077720 |
37 | MP0003786_premature_aging | 1.59903550 |
38 | MP0002429_abnormal_blood_cell | 1.59222454 |
39 | MP0005671_abnormal_response_to | 1.58622230 |
40 | MP0001849_ear_inflammation | 1.57048257 |
41 | MP0000716_abnormal_immune_system | 1.56661753 |
42 | MP0002095_abnormal_skin_pigmentation | 1.55601508 |
43 | MP0002019_abnormal_tumor_incidence | 1.55311977 |
44 | MP0002249_abnormal_larynx_morphology | 1.54378795 |
45 | MP0000313_abnormal_cell_death | 1.51457532 |
46 | MP0000681_abnormal_thyroid_gland | 1.51265232 |
47 | MP0010030_abnormal_orbit_morphology | 1.50624413 |
48 | MP0002420_abnormal_adaptive_immunity | 1.50392031 |
49 | MP0002452_abnormal_antigen_presenting | 1.49509125 |
50 | MP0009379_abnormal_foot_pigmentation | 1.48840716 |
51 | MP0002877_abnormal_melanocyte_morpholog | 1.48190144 |
52 | MP0001819_abnormal_immune_cell | 1.47627028 |
53 | MP0005076_abnormal_cell_differentiation | 1.46614674 |
54 | MP0001873_stomach_inflammation | 1.46420558 |
55 | MP0000015_abnormal_ear_pigmentation | 1.41205927 |
56 | MP0003191_abnormal_cellular_cholesterol | 1.41023909 |
57 | MP0004947_skin_inflammation | 1.36973162 |
58 | MP0002080_prenatal_lethality | 1.34308876 |
59 | MP0005666_abnormal_adipose_tissue | 1.34208376 |
60 | MP0002166_altered_tumor_susceptibility | 1.33985183 |
61 | MP0003453_abnormal_keratinocyte_physiol | 1.33172078 |
62 | MP0003866_abnormal_defecation | 1.32862721 |
63 | MP0004858_abnormal_nervous_system | 1.31550039 |
64 | MP0002723_abnormal_immune_serum | 1.31314883 |
65 | MP0010307_abnormal_tumor_latency | 1.30427557 |
66 | MP0001853_heart_inflammation | 1.26751560 |
67 | MP0003656_abnormal_erythrocyte_physiolo | 1.25376425 |
68 | MP0003172_abnormal_lysosome_physiology | 1.24766731 |
69 | MP0003123_paternal_imprinting | 1.24552938 |
70 | MP0008877_abnormal_DNA_methylation | 1.21342879 |
71 | MP0003329_amyloid_beta_deposits | 1.18328899 |
72 | MP0002148_abnormal_hypersensitivity_rea | 1.17528377 |
73 | MP0003300_gastrointestinal_ulcer | 1.16196739 |
74 | MP0005025_abnormal_response_to | 1.15108950 |
75 | MP0001697_abnormal_embryo_size | 1.12990965 |
76 | MP0005501_abnormal_skin_physiology | 1.12027509 |
77 | MP0000003_abnormal_adipose_tissue | 1.11687494 |
78 | MP0010352_gastrointestinal_tract_polyps | 1.10545482 |
79 | MP0005464_abnormal_platelet_physiology | 1.09966760 |
80 | MP0005375_adipose_tissue_phenotype | 1.09260442 |
81 | MP0001661_extended_life_span | 1.09169425 |
82 | MP0005000_abnormal_immune_tolerance | 1.07848547 |
83 | MP0002405_respiratory_system_inflammati | 1.04314940 |
84 | MP0002132_abnormal_respiratory_system | 1.04238998 |
85 | MP0006292_abnormal_olfactory_placode | 1.04046470 |
86 | MP0009840_abnormal_foam_cell | 1.01851207 |
87 | MP0003567_abnormal_fetal_cardiomyocyte | 0.99271813 |
88 | MP0001672_abnormal_embryogenesis/_devel | 0.99204090 |
89 | MP0005380_embryogenesis_phenotype | 0.99204090 |
90 | MP0003121_genomic_imprinting | 0.98444770 |
91 | MP0002102_abnormal_ear_morphology | 0.97195589 |
92 | MP0004381_abnormal_hair_follicle | 0.96982719 |
93 | MP0004147_increased_porphyrin_level | 0.96458974 |
94 | MP0008469_abnormal_protein_level | 0.93477380 |
95 | MP0009278_abnormal_bone_marrow | 0.93448869 |
96 | MP0009785_altered_susceptibility_to | 0.92705229 |
97 | MP0002085_abnormal_embryonic_tissue | 0.92592116 |
98 | MP0000858_altered_metastatic_potential | 0.92460188 |
99 | MP0001845_abnormal_inflammatory_respons | 0.91991909 |
100 | MP0001790_abnormal_immune_system | 0.90836646 |
101 | MP0005387_immune_system_phenotype | 0.90836646 |
102 | MP0003984_embryonic_growth_retardation | 0.90224295 |
103 | MP0000604_amyloidosis | 0.88940266 |
104 | MP0010155_abnormal_intestine_physiology | 0.87572429 |
105 | MP0000747_muscle_weakness | 0.87571197 |
106 | MP0009931_abnormal_skin_appearance | 0.87039893 |
107 | MP0006036_abnormal_mitochondrial_physio | 0.86516465 |
108 | MP0002075_abnormal_coat/hair_pigmentati | 0.86458641 |
109 | MP0002088_abnormal_embryonic_growth/wei | 0.86120697 |
110 | MP0003436_decreased_susceptibility_to | 0.85754598 |
111 | MP0004233_abnormal_muscle_weight | 0.84803439 |
112 | MP0002419_abnormal_innate_immunity | 0.84299688 |
113 | MP0002970_abnormal_white_adipose | 0.84173105 |
114 | MP0005670_abnormal_white_adipose | 0.83790105 |
115 | MP0002006_tumorigenesis | 0.83636333 |
116 | MP0000477_abnormal_intestine_morphology | 0.79749088 |
117 | MP0005310_abnormal_salivary_gland | 0.79041041 |
118 | MP0005171_absent_coat_pigmentation | 0.78732129 |
119 | MP0002086_abnormal_extraembryonic_tissu | 0.78202768 |
120 | MP0001293_anophthalmia | 0.77563361 |
121 | MP0000343_altered_response_to | 0.77251157 |
122 | MP0000358_abnormal_cell_content/ | 0.76504354 |
123 | MP0002084_abnormal_developmental_patter | 0.75608225 |
124 | MP0000371_diluted_coat_color | 0.75486784 |
125 | MP0002210_abnormal_sex_determination | 0.74929204 |
126 | MP0001986_abnormal_taste_sensitivity | 0.74545741 |
127 | MP0000609_abnormal_liver_physiology | 0.74428019 |
128 | MP0001764_abnormal_homeostasis | 0.73863789 |
129 | MP0003315_abnormal_perineum_morphology | 0.73625056 |
130 | MP0001145_abnormal_male_reproductive | 0.72454973 |
131 | MP0005384_cellular_phenotype | 0.72246801 |
132 | MP0004197_abnormal_fetal_growth/weight/ | 0.71942017 |
133 | MP0005058_abnormal_lysosome_morphology | 0.71216650 |
134 | MP0001533_abnormal_skeleton_physiology | 0.71175069 |
135 | MP0005621_abnormal_cell_physiology | 0.67595387 |
136 | MP0000049_abnormal_middle_ear | 0.63746450 |
137 | MP0006035_abnormal_mitochondrial_morpho | 0.63209563 |
138 | MP0001186_pigmentation_phenotype | 0.62719982 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.32093054 |
2 | Abnormal number of erythroid precursors (HP:0012131) | 6.05018248 |
3 | Reticulocytopenia (HP:0001896) | 5.83531074 |
4 | Pallor (HP:0000980) | 4.48206203 |
5 | Aplastic anemia (HP:0001915) | 4.16574107 |
6 | Thrombocytosis (HP:0001894) | 3.94961409 |
7 | Hypertensive crisis (HP:0100735) | 3.83646510 |
8 | Truncus arteriosus (HP:0001660) | 3.81890074 |
9 | Macrocytic anemia (HP:0001972) | 3.66243725 |
10 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.41714459 |
11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.41714459 |
12 | IgM deficiency (HP:0002850) | 3.41007626 |
13 | Obstructive lung disease (HP:0006536) | 3.39876437 |
14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.39876437 |
15 | Colon cancer (HP:0003003) | 3.30861267 |
16 | Seborrheic dermatitis (HP:0001051) | 3.23509895 |
17 | Birth length less than 3rd percentile (HP:0003561) | 3.22777945 |
18 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.19598653 |
19 | Hyperthyroidism (HP:0000836) | 3.15693002 |
20 | Oral leukoplakia (HP:0002745) | 3.02208269 |
21 | Colitis (HP:0002583) | 2.92821419 |
22 | Reticulocytosis (HP:0001923) | 2.92408227 |
23 | Selective tooth agenesis (HP:0001592) | 2.88964498 |
24 | Myelodysplasia (HP:0002863) | 2.81867506 |
25 | Abnormality of the anterior horn cell (HP:0006802) | 2.79230297 |
26 | Degeneration of anterior horn cells (HP:0002398) | 2.79230297 |
27 | Abnormal gallbladder physiology (HP:0012438) | 2.79200461 |
28 | Cholecystitis (HP:0001082) | 2.79200461 |
29 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.75401168 |
30 | 11 pairs of ribs (HP:0000878) | 2.73768159 |
31 | Agnosia (HP:0010524) | 2.63145585 |
32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.62653848 |
33 | Increased serum ferritin (HP:0003281) | 2.61980698 |
34 | Chronic otitis media (HP:0000389) | 2.60809616 |
35 | Type I transferrin isoform profile (HP:0003642) | 2.59564721 |
36 | Hyperacusis (HP:0010780) | 2.58511395 |
37 | Recurrent abscess formation (HP:0002722) | 2.56055409 |
38 | Ulnar bowing (HP:0003031) | 2.54824885 |
39 | Broad distal phalanx of finger (HP:0009836) | 2.54800846 |
40 | Microretrognathia (HP:0000308) | 2.54461827 |
41 | Abnormal large intestine physiology (HP:0012700) | 2.52310963 |
42 | Lymphoma (HP:0002665) | 2.52266802 |
43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51530979 |
44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51530979 |
45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51530979 |
46 | Eczematoid dermatitis (HP:0000976) | 2.50036608 |
47 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.49505631 |
48 | Recurrent bacterial skin infections (HP:0005406) | 2.49203975 |
49 | Testicular atrophy (HP:0000029) | 2.47647596 |
50 | Petechiae (HP:0000967) | 2.47444917 |
51 | Bone marrow hypocellularity (HP:0005528) | 2.46430240 |
52 | Rough bone trabeculation (HP:0100670) | 2.45326486 |
53 | Poikiloderma (HP:0001029) | 2.44903433 |
54 | Bowel incontinence (HP:0002607) | 2.44739638 |
55 | Abnormality of the thoracic spine (HP:0100711) | 2.44455799 |
56 | Absent thumb (HP:0009777) | 2.43292935 |
57 | Ragged-red muscle fibers (HP:0003200) | 2.42776091 |
58 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.42114121 |
59 | Atelectasis (HP:0100750) | 2.41787525 |
60 | Premature graying of hair (HP:0002216) | 2.40426546 |
61 | Pancytopenia (HP:0001876) | 2.39702395 |
62 | Stridor (HP:0010307) | 2.39253579 |
63 | Dysostosis multiplex (HP:0000943) | 2.37411560 |
64 | Chromsome breakage (HP:0040012) | 2.35391534 |
65 | Basal cell carcinoma (HP:0002671) | 2.34749762 |
66 | Annular pancreas (HP:0001734) | 2.34129712 |
67 | Increased cerebral lipofuscin (HP:0011813) | 2.29428198 |
68 | Myopathic facies (HP:0002058) | 2.29137553 |
69 | Abnormality of T cell physiology (HP:0011840) | 2.27633072 |
70 | Patellar aplasia (HP:0006443) | 2.22838692 |
71 | Abnormality of the preputium (HP:0100587) | 2.21607511 |
72 | Hemorrhage of the eye (HP:0011885) | 2.21539329 |
73 | Asplenia (HP:0001746) | 2.19354002 |
74 | Abnormal number of incisors (HP:0011064) | 2.19232837 |
75 | Abnormality of the tricuspid valve (HP:0001702) | 2.18488662 |
76 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.18038002 |
77 | Abnormality of DNA repair (HP:0003254) | 2.17717322 |
78 | Abnormal protein glycosylation (HP:0012346) | 2.17353061 |
79 | Abnormal glycosylation (HP:0012345) | 2.17353061 |
80 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.17353061 |
81 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.17353061 |
82 | Hepatosplenomegaly (HP:0001433) | 2.16450285 |
83 | Reduced antithrombin III activity (HP:0001976) | 2.14955480 |
84 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.12542791 |
85 | Microvesicular hepatic steatosis (HP:0001414) | 2.12169161 |
86 | B lymphocytopenia (HP:0010976) | 2.11119078 |
87 | Abnormality of B cell number (HP:0010975) | 2.11119078 |
88 | Purpura (HP:0000979) | 2.10681309 |
89 | Hypoplasia of the radius (HP:0002984) | 2.10223488 |
90 | Cholelithiasis (HP:0001081) | 2.10110624 |
91 | Medulloblastoma (HP:0002885) | 2.10081277 |
92 | Neoplasm of the pancreas (HP:0002894) | 2.09928420 |
93 | Recurrent bronchitis (HP:0002837) | 2.09781355 |
94 | Thoracic kyphosis (HP:0002942) | 2.09363293 |
95 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.08477117 |
96 | Vertebral compression fractures (HP:0002953) | 2.07388325 |
97 | Abnormality of chromosome stability (HP:0003220) | 2.06890610 |
98 | Breast hypoplasia (HP:0003187) | 2.06328041 |
99 | Abnormality of the ileum (HP:0001549) | 2.06074222 |
100 | Cleft eyelid (HP:0000625) | 2.05858738 |
101 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05784206 |
102 | Fatigue (HP:0012378) | 2.05744425 |
103 | Achilles tendon contracture (HP:0001771) | 2.04993444 |
104 | Ependymoma (HP:0002888) | 2.04898841 |
105 | Meckel diverticulum (HP:0002245) | 2.04664933 |
106 | Mediastinal lymphadenopathy (HP:0100721) | 2.04315602 |
107 | Panhypogammaglobulinemia (HP:0003139) | 2.04111207 |
108 | Abnormality of reticulocytes (HP:0004312) | 2.03951191 |
109 | Abnormality of macrophages (HP:0004311) | 2.02531568 |
110 | Acute lymphatic leukemia (HP:0006721) | 2.02302849 |
111 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.00760401 |
112 | Nonimmune hydrops fetalis (HP:0001790) | 1.99845714 |
113 | Entropion (HP:0000621) | 1.99600192 |
114 | Cellulitis (HP:0100658) | 1.99509251 |
115 | Small intestinal stenosis (HP:0012848) | 1.99105952 |
116 | Duodenal stenosis (HP:0100867) | 1.99105952 |
117 | Cerebral hypomyelination (HP:0006808) | 1.96114007 |
118 | Thin bony cortex (HP:0002753) | 1.95974620 |
119 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.95973105 |
120 | Progressive muscle weakness (HP:0003323) | 1.95837292 |
121 | Trismus (HP:0000211) | 1.95586114 |
122 | Hypertriglyceridemia (HP:0002155) | 1.95567986 |
123 | Squamous cell carcinoma (HP:0002860) | 1.95494699 |
124 | Hypoparathyroidism (HP:0000829) | 1.93749881 |
125 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.93682902 |
126 | Recurrent viral infections (HP:0004429) | 1.93071721 |
127 | Abnormality of T cells (HP:0002843) | 1.92014777 |
128 | Leukopenia (HP:0001882) | 1.91798095 |
129 | Poor head control (HP:0002421) | 1.91398992 |
130 | Cellular immunodeficiency (HP:0005374) | 1.90531365 |
131 | Premature skin wrinkling (HP:0100678) | 1.90230448 |
132 | Inflammation of the large intestine (HP:0002037) | 1.89466638 |
133 | Polycythemia (HP:0001901) | 1.88769288 |
134 | Slender long bone (HP:0003100) | 1.88499020 |
135 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.88322477 |
136 | Depressed nasal ridge (HP:0000457) | 1.87025692 |
137 | Distal lower limb amyotrophy (HP:0008944) | 1.85044320 |
138 | Long palpebral fissure (HP:0000637) | 1.84854856 |
139 | Slow saccadic eye movements (HP:0000514) | 1.84285393 |
140 | Increased IgE level (HP:0003212) | 1.83986092 |
141 | Lymphopenia (HP:0001888) | 1.83945876 |
142 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.83876306 |
143 | Patellar dislocation (HP:0002999) | 1.83798660 |
144 | Gastrointestinal inflammation (HP:0004386) | 1.83153660 |
145 | Disproportionate tall stature (HP:0001519) | 1.82712951 |
146 | Severe visual impairment (HP:0001141) | 1.81821790 |
147 | Abnormality of the columella (HP:0009929) | 1.81798428 |
148 | Abnormality of the fingertips (HP:0001211) | 1.81737503 |
149 | Meningitis (HP:0001287) | 1.80747302 |
150 | Triphalangeal thumb (HP:0001199) | 1.80003961 |
151 | Interstitial pulmonary disease (HP:0006530) | 1.78812669 |
152 | Increased serum lactate (HP:0002151) | 1.78806779 |
153 | Gastrointestinal dysmotility (HP:0002579) | 1.78793464 |
154 | Amaurosis fugax (HP:0100576) | 1.78709586 |
155 | Recurrent fungal infections (HP:0002841) | 1.78282067 |
156 | Volvulus (HP:0002580) | 1.78274434 |
157 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.78039353 |
158 | Prominent nose (HP:0000448) | 1.76705865 |
159 | Progressive external ophthalmoplegia (HP:0000590) | 1.76705749 |
160 | Hepatocellular necrosis (HP:0001404) | 1.76480255 |
161 | Prolonged neonatal jaundice (HP:0006579) | 1.76115486 |
162 | Glossoptosis (HP:0000162) | 1.76021321 |
163 | Prolonged bleeding time (HP:0003010) | 1.75910291 |
164 | Abnormality of iron homeostasis (HP:0011031) | 1.75272712 |
165 | Abnormality of the gallbladder (HP:0005264) | 1.73402119 |
166 | Joint stiffness (HP:0001387) | 1.73067626 |
167 | Vaginal fistula (HP:0004320) | 1.72079714 |
168 | Biconcave vertebral bodies (HP:0004586) | 1.71432910 |
169 | Abnormality of the Achilles tendon (HP:0005109) | 1.70908018 |
170 | Loss of speech (HP:0002371) | 1.70559937 |
171 | Abnormality of lateral ventricle (HP:0030047) | 1.69282481 |
172 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.69135226 |
173 | Increased muscle lipid content (HP:0009058) | 1.68778616 |
174 | Broad face (HP:0000283) | 1.64965821 |
175 | Neuronal loss in central nervous system (HP:0002529) | 1.64640892 |
176 | Flared metaphyses (HP:0003015) | 1.63587975 |
177 | Abnormality of the nasal mucosa (HP:0000433) | 1.63383327 |
178 | Intestinal fistula (HP:0100819) | 1.62632723 |
179 | Dysautonomia (HP:0002459) | 1.62529447 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 3.84110271 |
2 | EIF2AK1 | 3.81950028 |
3 | STK16 | 3.81573612 |
4 | TLK1 | 3.67300943 |
5 | IRAK3 | 3.22538269 |
6 | SMG1 | 3.21706126 |
7 | WEE1 | 2.99712859 |
8 | MAP4K1 | 2.91020641 |
9 | PRPF4B | 2.85365826 |
10 | CDC7 | 2.69733754 |
11 | NME2 | 2.68288170 |
12 | FLT3 | 2.14512381 |
13 | EEF2K | 2.05827184 |
14 | ICK | 2.05641174 |
15 | VRK1 | 2.01627690 |
16 | NEK2 | 2.00275557 |
17 | PASK | 1.91238573 |
18 | RIPK4 | 1.88291080 |
19 | DYRK3 | 1.85926919 |
20 | SIK1 | 1.82873672 |
21 | SRPK1 | 1.81259097 |
22 | ACVR1B | 1.74107427 |
23 | TSSK6 | 1.73585979 |
24 | TESK2 | 1.68869809 |
25 | CDK12 | 1.66945312 |
26 | BRSK2 | 1.64718848 |
27 | SCYL2 | 1.61210519 |
28 | RPS6KB2 | 1.60824915 |
29 | MAP3K10 | 1.58773135 |
30 | CDK19 | 1.53658023 |
31 | BTK | 1.50724947 |
32 | MAP2K3 | 1.47132340 |
33 | EIF2AK3 | 1.46591282 |
34 | TAOK2 | 1.44061960 |
35 | ATR | 1.43611713 |
36 | MAP3K13 | 1.40041474 |
37 | PIM2 | 1.39635272 |
38 | CDK4 | 1.36313477 |
39 | MKNK1 | 1.31807858 |
40 | KIT | 1.31500591 |
41 | LRRK2 | 1.31434570 |
42 | ZAP70 | 1.30769393 |
43 | RPS6KA4 | 1.29048067 |
44 | TAOK3 | 1.24799220 |
45 | MAPK11 | 1.24429862 |
46 | TGFBR1 | 1.23836901 |
47 | CDK7 | 1.21598558 |
48 | TNK2 | 1.17270569 |
49 | KSR2 | 1.17262371 |
50 | CSF1R | 1.17205846 |
51 | CCNB1 | 1.14203453 |
52 | BLK | 1.13825628 |
53 | TEC | 1.12951653 |
54 | AURKB | 1.11659779 |
55 | ARAF | 1.10716805 |
56 | STK10 | 1.07070805 |
57 | PDPK1 | 1.06502276 |
58 | PLK1 | 1.05554178 |
59 | MAP3K14 | 1.04707437 |
60 | PKN2 | 1.00418693 |
61 | MARK2 | 0.99879630 |
62 | MKNK2 | 0.98121182 |
63 | PAK4 | 0.97347018 |
64 | MAP3K8 | 0.97251502 |
65 | CLK1 | 0.97187920 |
66 | CAMKK2 | 0.97020023 |
67 | GRK6 | 0.96613423 |
68 | MAP3K11 | 0.95581703 |
69 | TESK1 | 0.95028190 |
70 | ERN1 | 0.93771198 |
71 | TTK | 0.93540990 |
72 | MAP3K1 | 0.92634313 |
73 | SYK | 0.91497166 |
74 | PRKD2 | 0.91004913 |
75 | IRAK2 | 0.88115606 |
76 | KDR | 0.87643378 |
77 | MAPK12 | 0.83770220 |
78 | PRKD3 | 0.83609500 |
79 | CDK8 | 0.83315085 |
80 | MAP3K3 | 0.81121903 |
81 | PIM1 | 0.81082066 |
82 | CHEK2 | 0.80527799 |
83 | MTOR | 0.79813476 |
84 | BRSK1 | 0.78511514 |
85 | MAPK15 | 0.77988517 |
86 | RPS6KC1 | 0.73881928 |
87 | RPS6KL1 | 0.73881928 |
88 | BCKDK | 0.73847229 |
89 | AURKA | 0.71504191 |
90 | MATK | 0.69013160 |
91 | TAOK1 | 0.68681077 |
92 | PTK6 | 0.68117348 |
93 | CDC42BPA | 0.68062476 |
94 | MAP2K2 | 0.67905588 |
95 | JAK3 | 0.67159921 |
96 | PDK1 | 0.66964180 |
97 | CHEK1 | 0.66416234 |
98 | BRD4 | 0.66344191 |
99 | BMX | 0.63452469 |
100 | NME1 | 0.63347211 |
101 | FGFR4 | 0.62581505 |
102 | HIPK2 | 0.61825705 |
103 | LYN | 0.59488796 |
104 | TTN | 0.59292538 |
105 | MAPKAPK3 | 0.59278705 |
106 | CSK | 0.58940183 |
107 | BRAF | 0.58705806 |
108 | MAP2K6 | 0.57181969 |
109 | STK4 | 0.56346300 |
110 | RPS6KA6 | 0.56221776 |
111 | IRAK4 | 0.55555505 |
112 | CDK2 | 0.55530258 |
113 | PLK4 | 0.55065047 |
114 | EPHB1 | 0.54932423 |
115 | CAMK1D | 0.54762056 |
116 | CSNK2A2 | 0.54382967 |
117 | RPS6KA2 | 0.54307274 |
118 | VRK2 | 0.51979612 |
119 | HCK | 0.51811124 |
120 | FES | 0.51674226 |
121 | TRIB3 | 0.50714592 |
122 | IKBKE | 0.50281165 |
123 | MAP3K7 | 0.48325691 |
124 | ILK | 0.47921904 |
125 | CSNK2A1 | 0.46912000 |
126 | TXK | 0.46023856 |
127 | SIK2 | 0.45334927 |
128 | TYK2 | 0.45199002 |
129 | LCK | 0.44790743 |
130 | PAK1 | 0.44267198 |
131 | CDK6 | 0.43129470 |
132 | TGFBR2 | 0.42428862 |
133 | DAPK1 | 0.41628885 |
134 | ZAK | 0.41272839 |
135 | RPS6KA5 | 0.40004390 |
136 | MAPK7 | 0.38718512 |
137 | DYRK1B | 0.38554978 |
138 | ATM | 0.37610449 |
139 | JAK2 | 0.36705364 |
140 | UHMK1 | 0.36630543 |
141 | PLK3 | 0.33597236 |
142 | SIK3 | 0.33092051 |
143 | PRKCI | 0.32437044 |
144 | TBK1 | 0.31994429 |
145 | CDK1 | 0.31868305 |
146 | AKT2 | 0.31497630 |
147 | IKBKB | 0.29859831 |
148 | MAP3K12 | 0.29309596 |
149 | RAF1 | 0.25726773 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 5.29602744 |
2 | Ribosome_Homo sapiens_hsa03010 | 4.66579718 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 4.35866544 |
4 | Base excision repair_Homo sapiens_hsa03410 | 3.31879830 |
5 | Spliceosome_Homo sapiens_hsa03040 | 3.30524513 |
6 | Homologous recombination_Homo sapiens_hsa03440 | 2.92172177 |
7 | RNA polymerase_Homo sapiens_hsa03020 | 2.89247545 |
8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.70216349 |
9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.65387527 |
10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.59689384 |
11 | Proteasome_Homo sapiens_hsa03050 | 2.48988551 |
12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.32341076 |
13 | RNA transport_Homo sapiens_hsa03013 | 2.30865740 |
14 | Cell cycle_Homo sapiens_hsa04110 | 2.19259843 |
15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.06311183 |
16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.99537020 |
17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.80944069 |
18 | Protein export_Homo sapiens_hsa03060 | 1.65469874 |
19 | RNA degradation_Homo sapiens_hsa03018 | 1.63670099 |
20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.53306334 |
21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.38665344 |
22 | Purine metabolism_Homo sapiens_hsa00230 | 1.37611884 |
23 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.33105374 |
24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32572898 |
25 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.31901133 |
26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27633454 |
27 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.27127148 |
28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26943331 |
29 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.26206112 |
30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.23025759 |
31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.20831882 |
32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.19793437 |
33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.18413785 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09849835 |
35 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.08869338 |
36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05160149 |
37 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95052514 |
38 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89056289 |
39 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88496929 |
40 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88492548 |
41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87545280 |
42 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86574478 |
43 | Tuberculosis_Homo sapiens_hsa05152 | 0.85815611 |
44 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.85432191 |
45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84108633 |
46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83130271 |
47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82088842 |
48 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82071546 |
49 | Hepatitis C_Homo sapiens_hsa05160 | 0.81441186 |
50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79061162 |
51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78621759 |
52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77635384 |
53 | Prion diseases_Homo sapiens_hsa05020 | 0.73906578 |
54 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73233561 |
55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70855944 |
56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70725554 |
57 | Measles_Homo sapiens_hsa05162 | 0.70194409 |
58 | Allograft rejection_Homo sapiens_hsa05330 | 0.69890903 |
59 | Alcoholism_Homo sapiens_hsa05034 | 0.69492378 |
60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67101783 |
61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66916551 |
62 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.65666836 |
63 | Shigellosis_Homo sapiens_hsa05131 | 0.63580952 |
64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62119638 |
65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60962327 |
66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60893890 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58760170 |
68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57471382 |
69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57117683 |
70 | Glioma_Homo sapiens_hsa05214 | 0.56021264 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55549019 |
72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55099357 |
73 | Hepatitis B_Homo sapiens_hsa05161 | 0.54811223 |
74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53888498 |
75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53400796 |
76 | Apoptosis_Homo sapiens_hsa04210 | 0.53213156 |
77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52980151 |
78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52474532 |
79 | Asthma_Homo sapiens_hsa05310 | 0.52034534 |
80 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50171605 |
81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49759930 |
82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49589944 |
83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47704508 |
84 | Salmonella infection_Homo sapiens_hsa05132 | 0.47250348 |
85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47109149 |
86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46697740 |
87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46344994 |
88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46007995 |
89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45663295 |
90 | Legionellosis_Homo sapiens_hsa05134 | 0.45231738 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.45030135 |
92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44900128 |
93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44549809 |
94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43486937 |
95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42739524 |
96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42508151 |
97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41842338 |
98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41595540 |
99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40140431 |
100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39758472 |
101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.39214626 |
102 | Influenza A_Homo sapiens_hsa05164 | 0.38465955 |
103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37812575 |
104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36979187 |
105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36719079 |
106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36673418 |
107 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35814855 |
108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35752132 |
109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34869148 |
110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33914639 |
111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31655658 |
112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31426062 |
113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31379843 |
114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27839103 |
115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27363887 |
116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26489954 |
117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.25792515 |
118 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.25115530 |
119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25102738 |
120 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.24789679 |
121 | Platelet activation_Homo sapiens_hsa04611 | 0.22259778 |
122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.22188780 |
123 | Bladder cancer_Homo sapiens_hsa05219 | 0.21763593 |
124 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.21655105 |
125 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.21256822 |
126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20626661 |
127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.18402207 |
128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18191756 |
129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18075503 |
130 | Lysosome_Homo sapiens_hsa04142 | 0.17736434 |
131 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17603514 |
132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16677373 |
133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13947150 |